PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 185 filers reported holding PROVENTION BIO INC in Q1 2023. The put-call ratio across all filers is 1.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $443,440 | +128.0% | 18,400 | 0.0% | 0.05% | +91.7% |
| Q4 2022 | $194,488 | +146.2% | 18,400 | +5.1% | 0.02% | +118.2% |
| Q3 2022 | $79,000 | +17.9% | 17,500 | +4.8% | 0.01% | +22.2% |
| Q2 2022 | $67,000 | -45.1% | 16,700 | 0.0% | 0.01% | -35.7% |
| Q1 2022 | $122,000 | +29.8% | 16,700 | 0.0% | 0.01% | +40.0% |
| Q4 2021 | $94,000 | -17.5% | 16,700 | -6.2% | 0.01% | +400.0% |
| Q3 2021 | $114,000 | -24.0% | 17,800 | 0.0% | 0.00% | -88.9% |
| Q2 2021 | $150,000 | -15.3% | 17,800 | +5.3% | 0.02% | -21.7% |
| Q1 2021 | $177,000 | -35.9% | 16,900 | +3.7% | 0.02% | -42.5% |
| Q4 2020 | $276,000 | -99.9% | 16,300 | +1.9% | 0.04% | +14.3% |
| Q3 2020 | $205,280,000 | +90731.9% | 16,000 | 0.0% | 0.04% | -18.6% |
| Q2 2020 | $226,000 | +58.0% | 16,000 | +3.2% | 0.04% | +30.3% |
| Q1 2020 | $143,000 | -99.9% | 15,500 | 0.0% | 0.03% | -17.5% |
| Q4 2019 | $230,950,000 | +217777.4% | 15,500 | 0.0% | 0.04% | +90.5% |
| Q3 2019 | $106,000 | – | 15,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 217,050 | $2,278,000 | 1.60% |
| Perceptive Advisors | 2,852,058 | $29,932,000 | 0.38% |
| 683 Capital Management, LLC | 630,000 | $6,612,000 | 0.35% |
| ADVISORY RESEARCH INC | 237,500 | $2,493,000 | 0.18% |
| GILDER GAGNON HOWE & CO LLC | 3,109,874 | $32,638,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,195 | $2,594,000 | 0.08% |
| Virtus ETF Advisers LLC | 16,158 | $170,000 | 0.07% |
| Walleye Capital LLC | 103,823 | $1,090,000 | 0.06% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 22,755 | $239,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 29,384 | $308,000 | 0.05% |